Oragenics, Inc. (OGEN)

Oragenics Statistics

Total Valuation

Oragenics has a market cap or net worth of $2.53 million. The enterprise value is -$3.62 million.

Market Cap	2.53M
Enterprise Value	-3.62M

Important Dates

The last earnings date was Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

Oragenics has 4.34 million shares outstanding. The number of shares has increased by 797.06% in one year.

Current Share Class	4.34M
Shares Outstanding	4.34M
Shares Change (YoY)	+797.06%
Shares Change (QoQ)	+1.58%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	4.99%
Float	4.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.41
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.73, with a Debt / Equity ratio of 0.01.

Current Ratio	5.73
Quick Ratio	4.67
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.24

Financial Efficiency

Return on equity (ROE) is -311.00% and return on invested capital (ROIC) is -134.27%.

Return on Equity (ROE)	-311.00%
Return on Assets (ROA)	-105.56%
Return on Invested Capital (ROIC)	-134.27%
Return on Capital Employed (ROCE)	-155.17%
Weighted Average Cost of Capital (WACC)	29.69%
Revenue Per Employee	n/a
Profits Per Employee	-$3.28M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-159,535
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.20% in the last 52 weeks. The beta is 1.26, so Oragenics's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	-90.20%
50-Day Moving Average	0.65
200-Day Moving Average	0.93
Relative Strength Index (RSI)	44.47
Average Volume (20 Days)	47,891

Short Selling Information

The latest short interest is 703,470, so 16.22% of the outstanding shares have been sold short.

Short Interest	703,470
Short Previous Month	792,779
Short % of Shares Out	16.22%
Short % of Float	16.56%
Short Ratio (days to cover)	7.22

Income Statement

Revenue	n/a
Gross Profit	-2.39M
Operating Income	-9.59M
Pretax Income	-9.99M
Net Income	-9.83M
EBITDA	n/a
EBIT	-9.59M
Earnings Per Share (EPS)	-$3.19

Balance Sheet

The company has $6.11 million in cash and $56,134 in debt, with a net cash position of $6.05 million or $1.40 per share.

Cash & Cash Equivalents	6.11M
Total Debt	56,134
Net Cash	6.05M
Net Cash Per Share	$1.40
Equity (Book Value)	6.18M
Book Value Per Share	1.41
Working Capital	6.18M

Cash Flow

Operating Cash Flow	-9.33M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	-3.08M
Free Cash Flow	-9.33M
FCF Per Share	-$2.15

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oragenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-797.06%
Shareholder Yield	-797.06%
Earnings Yield	-404.62%
FCF Yield	-384.37%

Analyst Forecast

The average price target for Oragenics is $2.00, which is 242.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.00
Price Target Difference	242.17%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 3, 2025. It was a reverse split with a ratio of 1:30.

Last Split Date	Jun 3, 2025
Split Type	Reverse
Split Ratio	1:30

Scores

Altman Z-Score	n/a
Piotroski F-Score	2